1-(4-carboxyphenyl)-3,3-dimethyltriazene has been researched along with Brain Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benvenuto, J; Farquhar, D | 1 |
Giraldi, T; Grill, V; Mallardi, F; Perissin, L; Sava, G; Zorzet, S | 1 |
Giraldi, T; Lassiani, L; Nisi, C; Sava, G | 1 |
Crowther, D; Lee, SM; Margison, GP; Thatcher, N | 1 |
1 trial(s) available for 1-(4-carboxyphenyl)-3,3-dimethyltriazene and Brain Neoplasms
Article | Year |
---|---|
In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphocytes; Male; Melanoma; Methyltransferases; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Skin Neoplasms; Triazenes | 1992 |
3 other study(ies) available for 1-(4-carboxyphenyl)-3,3-dimethyltriazene and Brain Neoplasms
Article | Year |
---|---|
1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Dacarbazine; Drug Evaluation, Preclinical; Ependymoma; Leukemia L1210; Melanoma; Mice; Mice, Inbred Strains; Structure-Activity Relationship | 1984 |
Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cyclophosphamide; Dacarbazine; Leukemia, Experimental; Liver Neoplasms; Mice; Triazenes | 1984 |
Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes.
Topics: Animals; Antineoplastic Agents; Biotransformation; Brain Neoplasms; Dose-Response Relationship, Drug; Half-Life; Isomerism; Kinetics; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Structure-Activity Relationship; Triazenes | 1982 |